IDream Film Infrastructure Company Fund Raise of ₹270.4 Cr

IDream Film Infrastructure Company Board Meeting Date

IDream Film Infrastructure gave notice of a board meeting on 5 November 2026 to approve quarterly and half-year results. The agenda also includes a promoter reclassification request.

IDream Film Infrastructure Company Promoter Reclassification

IDream Film Infrastructure received a request from promoter Aha Holdings Pvt Ltd to reclassify from Promoter Group to Public. The holder shows Nil shares, and the Board will consider it at its next meeting.

IDream Film Infrastructure Company Other Announcement

IDream Film Infrastructure filed its quarterly shareholding pattern for the quarter ended 30 September 2026. This routine regulatory disclosure reports no corporate action or transaction.

IDream Film Infrastructure Company Other Announcement

The company has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.

IDream Film Infrastructure Company Other Announcement

IDream Film Infrastructure has appointed M/s. Ruchita Patel & Associates as its Secretarial Auditor for five years, following shareholder approval at the recent Annual General Meeting.

Idream Film Infrastructure Company Management Change

IDREAM Film Infrastructure announced multiple management changes, including new appointments and designations for Directors and Auditors, effective September 2026.

Rite Zone Chemcon India Fund Raise of ₹6.58 Cr

Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.

Value

₹6.58 Cr

Sudarshan Pharma Industries Fund Raise of ₹72 Cr

Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.

Value

₹72.00 Cr

Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr

Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.

Value

₹68.20 Cr

Kanel Industries Fund Raise of ₹16.99 Cr

Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.

Value

₹16.99 Cr

Execution

Rights issue opens 23 November 2026 and closes 30 November 2026

Sudarshan Pharma Industries Fund Raise

Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.

GAIL (India) Fund Raise

GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.